General Announcement::GPL to divest select Anti-Allergy brands to Dr Reddys in Russia,Ukraine, Kazakhstana & Uzbekistan

Issuer & Securities

Issuer/ Manager
GLENMARK PHARMACEUTICALS LIMITED
Securities
GLENMARK PH US$200M4.5%210802 - XS1456577334 - 4N4B
GLENMARK PHARM US$170M2%220628 - XS1426780125 - 4G8B
Stapled Security
No

Announcement Details

Announcement Title
General Announcement
Date &Time of Broadcast
28-Nov-2020 23:41:54
Status
New
Announcement Sub Title
GPL to divest select Anti-Allergy brands to Dr Reddys in Russia,Ukraine, Kazakhstana & Uzbekistan
Announcement Reference
SG201128OTHRBCMG
Submitted By (Co./ Ind. Name)
Glenmark Pharmaceuticals Limited
Designation
Company Secretary & Compliance Officer
Description (Please provide a detailed description of the event in the box below)
Glenmark to divest select Anti-Allergy brands to Dr Reddy s in Russia, Ukraine, Kazakhstan and Uzbekistan in anticipation of its Ryaltris Launch

Attachments

SGX_PR_28112020.pdf
Total size =1012K